NDC 62542-005-30
Amphetamine Extended-Release 3.1 mg/1
Amphetamine Extended-Release · TABLET, ORALLY DISINTEGRATING
Amphetamine Extended-Release is a prescription stimulant medication used to treat attention-deficit/hyperactivity disorder (ADHD) and narcolepsy by increasing focus and reducing impulsive behavior. This medication comes as an orally disintegrating tablet that dissolves in your mouth and is designed to provide effects throughout the day.
Key Facts
- Brand Name
- Amphetamine Extended-Release
- Generic Name
- Amphetamine Extended-Release
- NDC Code (Package)
62542-005-30- NDC Code (Product)
62542-005- Manufacturer
- Neos Therapeutics, LP
- Strength
- 3.1 mg/1
- Dosage Form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule II (Controlled)
- Application #
- NDA204326
- Drug Class
- Central Nervous System Stimulant [EPC]
- Marketing Start
- 09/01/2025
Recall History
No Recall HistoryView Full Drug Page
Amphetamine Extended-Release — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.